Open AccessIdentification of sequence polymorphisms in the displacement loop region of mitochondrial DNA as a risk factor for gastroenteropancreatic neuroendocrine neoplasm
Author(s) -
Er LiMian,
Wu MingLi,
Gao Yang,
Wang ShiJie,
Li Yong
Publication year - 2017
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.22078
Subject(s) - single nucleotide polymorphism , snp , biology , mitochondrial dna , genetics , allele , carcinogenesis , medicine , allele frequency , cancer , oncology , gene , genotype
Background Gastroenteropancreatic neuroendocrine neoplasms ( GEP ‐ NEN ) are relatively rare tumors that arise from the diffuse neuroendocrine system, and the biggest advances in molecular biology have helped in understanding these biological diversity of tumors over the past decades. It is important to determine the carcinogenesis of GEP ‐ NEN from the perspective of genetic backgrounds. Methods Mitochondrial DNA (mt DNA ) of peripheral blood from 66 GEP ‐ NEN patients and from 75 healthy controls without history of any cancer were examined for single nucleotide polymorphisms ( SNP s) and mutations in the displacement loop (D‐loop) region. Results Single nucleotide polymorphisms were detected in 148 sites within the 982 bp mitochondria D‐loop region from blood samples of healthy controls and GEP ‐ NEN patients. SNP s with a rare allele frequency >5% in either controls or GEP ‐ NEN patients were used for cancer risk analysis; a total of 23 SNP s were selected. When individual SNPs of GEP‐NEN patients compared with healthy controls were analyzed, a statistically significant increase in the SNP frequency was observed for 73G, 150T, 151T, 492C, 16257A, 16261T, and 16399G in GEP ‐ NEN patients ( P <.05). It was also observed that the SNP frequency for 489C and 16519C significantly decreased in GEP ‐ NEN patients compared with controls ( P <.05). Conclusion In summary, SNP s in the mutations of the mitochondrial D‐loop may be valuable markers for GEP ‐ NEN risk evaluation. Analysis of the genetic polymorphisms in the D‐loop may be useful for diagnosis of high‐risk individuals.